Human macrophages chronically exposed to LPS can be reactivated by stimulation with MDP to acquire an antimicrobial

Silvia Guzmán-Beltrán1, Martha Torres1, Monserrat Arellano1

  • 1Departamento de Investigación en Microbiología, Instituto Nacional de Enfermedades Respiratorias, México City, Mexico.

Cellular Immunology
|March 5, 2017
PubMed

Insights

This study shows that muramyl dipeptide (MDP) can reactivate endotoxin-tolerant macrophages, restoring their ability to produce key inflammatory cytokines and potentially enhancing immune responses against pathogens.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Macrophages are crucial for host defense, with M1 and M2 subsets.
  • Endotoxin tolerance in macrophages, caused by chronic lipopolysaccharide (LPS) exposure, impairs immune responses.
  • Tolerized macrophages exhibit reduced responsiveness to bacterial components like LPS.

Purpose of the Study:

  • To investigate the potential of muramyl dipeptide (MDP) to reactivate human monocyte-derived macrophages that are chronically exposed to LPS.
  • To assess the impact of MDP re-stimulation on the inflammatory and immune profiles of tolerized macrophages.

Main Methods:

  • Human monocyte-derived macrophages were chronically exposed to LPS to induce endotoxin tolerance.
  • Tolerized macrophages were re-stimulated with LPS and MDP.
  • Cell surface marker expression and cytokine production (TNFα, IL1, IL6, IFNγ, IL4, IL5, IL10) were analyzed.

Main Results:

  • Chronic LPS exposure led to an undefined cell surface marker profile and suppressed TNFα production.
  • Re-stimulation with LPS+MDP restored TNFα production in tolerized macrophages.
  • A significant increase in IL1, IL6, IFNγ, IL4, IL5, and IL10 production was observed after LPS+MDP treatment.

Conclusions:

  • Macrophages chronically exposed to LPS exhibit a mixed M1-M2 phenotype.
  • MDP re-stimulation can restore the inflammatory and immune potential of endotoxin-tolerant macrophages.
  • These findings suggest a potential therapeutic strategy for modulating macrophage function in inflammatory conditions.